Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 790 M2.13 B775 M1.43 B2.75 B1.07 B — Non-Operating Income, Total 89 M107 M113 M119 M99 M121 M — Interest expense, net of interest capitalized 468 M301 M504 M488 M246 M524 M — Non-Operating Income, excl. Interest Expenses -379 M-194 M-391 M-369 M-147 M-403 M — Unusual income/expense —————— — Pretax income 411 M1.94 B384 M1.06 B2.6 B671 M — Equity in earnings —————— — Taxes 3 M448 M-14 M175 M682 M101 M — Non-controlling/minority interest —————— — After tax other income/expense 38 M28 M49 M46 M53 M27 M — Net income before discontinued operations 408 M1.44 B343 M832 M1.85 B531 M — Discontinued operations —————— — Net income 408 M1.44 B343 M832 M1.85 B531 M — Dilution adjustment -46 M————— — Preferred dividends 22 M————— — Diluted net income available to common stockholders 340 M1.44 B344 M832 M1.85 B531 M — Basic earnings per share (Basic EPS) 0.883.730.892.164.81.38 — Diluted earnings per share (Diluted EPS) 0.873.720.892.154.791.37 — Average basic shares outstanding 386 M385 M385 M385 M385 M385 M — Diluted shares outstanding 388 M386 M386 M386 M386 M387 M — EBITDA 1.55 B2.88 B1.6 B2.29 B3.56 B1.91 B — EBIT 790 M2.13 B775 M1.43 B2.75 B1.07 B — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 756 M742 M826 M862 M807 M834 M —